Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,910Revenue $M3,050Net Margin (%)24.9Z-Score4.3
Enterprise Value $M11,499EPS $8.4Operating Margin %20.7F-Score6
P/E(ttm))15.5Cash Flow Per Share $8.0Pre-tax Margin (%)41.3Higher ROA y-yY
Price/Book5.610-y EBITDA Growth Rate %13.9Quick Ratio3.0Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %19.6Current Ratio3.7Lower Leverage y-yY
Price/Cash Flow12.2y-y EBITDA Growth Rate %83.3ROA % (ttm)16.9Higher Current Ratio y-yN
Dividend Yield %0.6Insider Buy (3m)1ROE % (ttm)44.4Less Shares Outstanding y-yY
Payout Ratio %8.0Shares Outstanding M76.3ROI % (ttm)5.1Gross Margin Increase y-yN

Gurus Latest Trades with BCR

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRJoel Greenblatt 2014-06-30 Add0.05%$136.23 - $149.25
($142.86)
$ 147.113%Add 187.29%40,174
BCRVanguard Health Care Fund 2014-06-30 Reduce-0.28%$136.23 - $149.25
($142.86)
$ 147.113%Reduce -37.07%1,157,400
BCRYacktman Fund 2014-06-30 Reduce-0.12%$136.23 - $149.25
($142.86)
$ 147.113%Reduce -2.76%3,330,000
BCRRay Dalio 2014-06-30 Reduce-0.02%$136.23 - $149.25
($142.86)
$ 147.113%Reduce -36.59%27,386
BCRVanguard Health Care Fund 2014-03-31 Add0.63%$125.42 - $146.57
($137.91)
$ 147.117%Add 505.6%1,839,200
BCRRay Dalio 2014-03-31 Add0.03%$125.42 - $146.57
($138.12)
$ 147.116%Add 118.27%43,186
BCRYacktman Focused Fund 2014-03-31 Reduce-0.91%$125.42 - $146.57
($137.91)
$ 147.117%Reduce -21.67%2,350,000
BCRDonald Yacktman 2014-03-31 Reduce-0.51%$125.42 - $146.57
($137.91)
$ 147.117%Reduce -11.96%6,827,627
BCRVanguard Health Care Fund 2013-12-31 Buy 0.13%$113.84 - $139.85
($132.09)
$ 147.1111%New holding, 303700 sh.303,700
BCRYacktman Focused Fund 2013-12-31 Reduce-1.7%$113.84 - $139.85
($132.09)
$ 147.1111%Reduce -29.91%3,000,000
BCRDonald Yacktman 2013-12-31 Reduce-1.09%$113.84 - $139.85
($132.09)
$ 147.1111%Reduce -21.46%7,755,464
BCRYacktman Fund 2013-12-31 Reduce-0.45%$113.84 - $139.85
($132.09)
$ 147.1111%Reduce -9.89%3,500,000
BCRRay Dalio 2013-12-31 Reduce-0.01%$113.84 - $139.85
($132.09)
$ 147.1111%Reduce -30.54%19,786
BCRRay Dalio 2013-09-30 Add0.01%$107.3 - $120.55
($114.78)
$ 147.1128%Add 24.47%28,486
BCRJeff Ubben 2013-09-30 Sold Out -0.85%$107.3 - $120.55
($114.78)
$ 147.1128%Sold Out0
BCRJoel Greenblatt 2013-09-30 Reduce-0.07%$107.3 - $120.55
($114.78)
$ 147.1128%Reduce -47.69%15,933
BCRYacktman Focused Fund 2013-06-30 Add1.26%$98.25 - $111.8
($104.06)
$ 147.1141%Add 27.8%4,280,000
BCRYacktman Fund 2013-06-30 Add1.06%$98.25 - $111.8
($104.06)
$ 147.1141%Add 29.9%3,884,100
BCRDonald Yacktman 2013-06-30 Add1%$98.25 - $111.8
($104.06)
$ 147.1141%Add 24.46%9,973,185
BCRJoel Greenblatt 2013-06-30 Add0.03%$98.25 - $111.8
($104.06)
$ 147.1141%Add 25.09%30,459
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BCR Joel Greenblatt 2014-06-3040,1740.050.07+187.29%
BCR Donald Yacktman 2014-06-306,701,2078.793.9-1.85%
BCR Yacktman Focused Fund 2014-06-302,300,0003.023.3-2.13%
BCR Yacktman Fund 2014-06-303,330,0004.374.1-2.76%
BCR Ray Dalio 2014-06-3027,3860.040.03-36.59%
BCR Vanguard Health Care Fund 2014-06-301,157,4001.520.44-37.07%
Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WEILAND JOHN HPresident and COO 2014-09-10Sell27,179$149.5-2.01view
RING TIMOTHY MChairman and CEO 2014-09-02Sell10,228$148.83-1.57view
KELLY BRONWEN KVP - Human Resources 2014-08-04Sell10,055$150.25-2.5view
RING TIMOTHY MChairman and CEO 2014-08-01Sell10,231$149.04-1.7view
Melcher David FDirector 2014-07-31Buy500$150.49-2.65view
Collins Timothy PGroup President 2014-07-30Sell30,914$150.38-2.58view
Luboff Sharon MGroup Vice President 2014-07-29Sell5,115$151.37-3.22view
Christian Patricia GVP -Quality, Reg & Med Affairs 2014-07-29Sell12,701$151.34-3.2view
RING TIMOTHY MChairman and CEO 2014-07-01Sell10,231$144.31.52view
RING TIMOTHY MChairman and CEO 2014-06-02Sell10,231$147.5-0.68view

Press Releases about BCR :

    Quarterly/Annual Reports about BCR:

    News about BCR:

    Articles On GuruFocus.com
    Medtronic Inc. (MDT) Dividend Stock Analysis Sep 12 2014 
    Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
    No More a Simple Distributor Sep 07 2014 
    Becton, Dickinson and Co. (BDX) Dividend Stock Analysis May 30 2014 
    CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
    Yacktman Funds Comments on C.R. Bard Inc. Mar 12 2014 
    Yacktman Fund Comments on C.R. Bard Inc. Jan 30 2014 
    Yacktman Focused Fund & Yacktman Fund Fourth Quarter Commentary Jan 30 2014 
    Weekly Insider Sells Highlight: BCR, GLUU, AMT, APOL, JACK Jan 20 2014 
    Yacktman Fund Buys Oracle, Exxon Mobil, C.R. Bard, Sells Pfizer, Viacom, Microsoft Jul 17 2013 

    More From Our Partners
    CR Bard Improves on Strong Product Strategy - Analyst Blog Sep 17 2014 - ZACKS

    More From Other Websites
    CR Bard Improves on Strong Product Strategy Sep 17 2014
    Boston Scientific ordered to pay $73 million over mesh device Sep 09 2014
    No More a Simple Distributor Sep 07 2014
    Medical Device Stocks Report Aug 20 2014
    5 Rocket Stocks to Buy for Correction Gains Aug 04 2014
    Terrance H. Gregg, the CEO of Dexcom, Inc. (DXCM), Interviews with The Wall Street Transcript Aug 01 2014
    BARD C R INC /NJ/ Financials Jul 31 2014
    C R Bard Q2 Earnings and Revenues Beat Estimates Jul 25 2014
    BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report Jul 25 2014
    C R Bard Inc Earnings Call scheduled for 5:00 pm ET today Jul 24 2014
    BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 24 2014
    Bard Announces Second Quarter Results Jul 24 2014
    Q2 2014 C. R. Bard, Inc. Earnings Release - After Market Close Jul 24 2014
    Why Lower-Yielding Stocks Provide Better Long-Term Returns Jul 10 2014
    3 Stocks Pulling The Health Services Industry Downward Jun 30 2014
    Headwinds For C.R. Bard, According To Barclays Jun 18 2014
    Will This Analyst Downgrade Hurt C.R. Bard (BCR) Stock Today? Jun 18 2014
    'Fast Money' Recap: Opening the Oil Spigot? Jun 17 2014
    CR Bard Expands Share Repurchase Program Jun 16 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK